Five Star Business Finance Share Price
Sector:
You have to be logged in to add this to Watchlist.
Login or Register
901.05 +6.60 (0.74%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
886
Today’s High
921.8
52 Week Low
601
52 Week High
903.2
900.40 +5.65 (0.63%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
885.75
Today’s High
921.7
52 Week Low
600.05
52 Week High
904
Key Metrics
- Market Cap (In Cr) 26335.48
- Beta -
- Div. Yield (%) 0
- P/B 5.07
- TTM P/E 25.64
- Peg Ratio 1.46
- Sector P/E 28.9
- D/E -
- Open Price 895.75
- Prev Close 894.45
Five Star Business Finance Analysis
Price Analysis
-
1 Week12.08%
-
3 Months15.34%
-
6 Month29.23%
-
YTD22.52%
-
1 Year14.51%
Risk Meter
- 36% Low risk
- 36% Moderate risk
- 36% Balanced Risk
- 36% High risk
- 36% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 3
- 3
- 3
- 3
- Buy
- 5
- 5
- 5
- 5
- Hold
- 0
- 0
- 0
- 0
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 9
- 9
- 9
- 9
Five Star Business Finance News
Stocks to Watch: Vedanta, SpiceJet, SBI, Piramal Pharma, Shriram Finance & more
4 min read . 26 Sep 2024Five Star Business Finance Q4 Results Live : profit rise by 39.78% YOY
1 min read . 03 May 2024Five Star Business Finance Q3 FY24 Results Live : profit rise by 43.55% YOY
1 min read . 04 Feb 2024Three global funding firms sell partial stake in Five Star Business Fin worth ₹1,656 crore
1 min read . 08 Dec 2023Five Star Business Finance Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2182.85
- Selling/ General/ Admin Expenses Total
- 428.59
- Depreciation/ Amortization
- 24.57
- Other Operating Expenses Total
- 102.14
- Total Operating Expense
- 610.67
- Operating Income
- 1572.18
- Net Income Before Taxes
- 1115.94
- Net Income
- 835.92
- Diluted Normalized EPS
- 29.8
- Period
- 2024
- Total Assets
- 11688.78
- Total Liabilities
- 6492.62
- Total Equity
- 5196.15
- Tangible Book Valueper Share Common Eq
- 177.35
- Period
- 2024
- Cashfrom Operating Activities
- -2122.34
- Cashfrom Investing Activities
- 210.16
- Cashfrom Financing Activities
- 2106.22
- Net Changein Cash
- 194.04
- Period
- 2023
- Total Revenue
- 1520.85
- Selling/ General/ Admin Expenses Total
- 420.45
- Depreciation/ Amortization
- 17.31
- Total Operating Expense
- 457.91
- Operating Income
- 1062.94
- Net Income Before Taxes
- 804.73
- Net Income
- 603.5
- Diluted Normalized EPS
- 21.01
- Period
- 2023
- Total Assets
- 8702.83
- Total Liabilities
- 4363.29
- Total Equity
- 4339.53
- Tangible Book Valueper Share Common Eq
- 148.9
- Period
- 2023
- Cashfrom Operating Activities
- -1122.81
- Cashfrom Investing Activities
- 161.78
- Cashfrom Financing Activities
- 1688.22
- Net Changein Cash
- 727.2
- Period
- 2022
- Total Revenue
- 1254.06
- Selling/ General/ Admin Expenses Total
- 293.58
- Depreciation/ Amortization
- 12.24
- Total Operating Expense
- 351.35
- Operating Income
- 902.72
- Net Income Before Taxes
- 604.21
- Net Income
- 453.54
- Diluted Normalized EPS
- 16.74
- Period
- 2022
- Total Assets
- 6343.07
- Total Liabilities
- 2632.71
- Total Equity
- 3710.35
- Tangible Book Valueper Share Common Eq
- 127.31
- Period
- 2022
- Cashfrom Operating Activities
- -277.16
- Cashfrom Investing Activities
- -383.88
- Cashfrom Financing Activities
- 7.02
- Net Changein Cash
- -654.02
- Period
- 2021
- Total Revenue
- 1049.74
- Selling/ General/ Admin Expenses Total
- 200.37
- Depreciation/ Amortization
- 11.38
- Total Operating Expense
- 249.6
- Operating Income
- 800.14
- Net Income Before Taxes
- 476.44
- Net Income
- 358.99
- Diluted Normalized EPS
- 13.23
- Period
- 2021
- Total Assets
- 5793.61
- Total Liabilities
- 3475.44
- Total Equity
- 2318.17
- Tangible Book Valueper Share Common Eq
- 79.5
- Period
- 2021
- Cashfrom Operating Activities
- -157.27
- Cashfrom Investing Activities
- 102.14
- Cashfrom Financing Activities
- 1032.53
- Net Changein Cash
- 977.4
- Period
- 2020
- Total Revenue
- 786.71
- Selling/ General/ Admin Expenses Total
- 161.27
- Depreciation/ Amortization
- 10.07
- Total Operating Expense
- 221.1
- Operating Income
- 565.61
- Net Income Before Taxes
- 349.3
- Net Income
- 261.95
- Diluted Normalized EPS
- 10.26
- Period
- 2020
- Total Assets
- 4353.15
- Total Liabilities
- 2408.57
- Total Equity
- 1944.58
- Tangible Book Valueper Share Common Eq
- 66.67
- Period
- 2020
- Cashfrom Operating Activities
- -1523.28
- Cashfrom Investing Activities
- -131.93
- Cashfrom Financing Activities
- 1725.34
- Net Changein Cash
- 70.12
- Period
- 2019
- Total Revenue
- 408.91
- Selling/ General/ Admin Expenses Total
- 101.86
- Depreciation/ Amortization
- 4.19
- Total Operating Expense
- 114.55
- Operating Income
- 294.36
- Net Income Before Taxes
- 218.44
- Net Income
- 156.66
- Diluted Normalized EPS
- 5.56
- Period
- 2019
- Total Assets
- 2349.83
- Total Liabilities
- 984.7
- Total Equity
- 1365.13
- Tangible Book Valueper Share Common Eq
- 46.78
- Period
- 2019
- Cashfrom Operating Activities
- -951.13
- Cashfrom Investing Activities
- 14.17
- Cashfrom Financing Activities
- 1025.19
- Net Changein Cash
- 88.23
- Period
- 2024-06-30
- Total Revenue
- 666.14
- Selling/ General/ Admin Expenses Total
- 122.81
- Depreciation/ Amortization
- 6.37
- Other Operating Expenses Total
- 27.29
- Total Operating Expense
- 175
- Operating Income
- 491.14
- Net Income Before Taxes
- 336.19
- Net Income
- 251.57
- Diluted Normalized EPS
- 9
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 616.29
- Selling/ General/ Admin Expenses Total
- 114.28
- Depreciation/ Amortization
- 7.4
- Other Operating Expenses Total
- 27.13
- Total Operating Expense
- 168.23
- Operating Income
- 448.06
- Net Income Before Taxes
- 313.19
- Net Income
- 236.06
- Diluted Normalized EPS
- 8.51
- Period
- 2024-03-31
- Total Assets
- 11688.78
- Total Liabilities
- 6492.62
- Total Equity
- 5196.15
- Tangible Book Valueper Share Common Eq
- 177.35
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -2122.34
- Cashfrom Investing Activities
- 210.16
- Cashfrom Financing Activities
- 2106.22
- Net Changein Cash
- 194.04
- Period
- 2023-12-31
- Total Revenue
- 567.37
- Selling/ General/ Admin Expenses Total
- 109.81
- Depreciation/ Amortization
- 6.64
- Other Operating Expenses Total
- 24.78
- Total Operating Expense
- 151.41
- Operating Income
- 415.96
- Net Income Before Taxes
- 289.91
- Net Income
- 216.76
- Diluted Normalized EPS
- 7.63
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 518.82
- Selling/ General/ Admin Expenses Total
- 105.79
- Depreciation/ Amortization
- 5.69
- Other Operating Expenses Total
- 27.45
- Total Operating Expense
- 149.5
- Operating Income
- 369.31
- Net Income Before Taxes
- 266.97
- Net Income
- 199.39
- Diluted Normalized EPS
- 7.04
- Period
- 2023-09-30
- Total Assets
- 9679.71
- Total Liabilities
- 4943.43
- Total Equity
- 4736.28
- Tangible Book Valueper Share Common Eq
- 161.99
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -983.93
- Cashfrom Investing Activities
- 49.05
- Cashfrom Financing Activities
- 609.95
- Net Changein Cash
- -324.93
- Period
- 2023-06-30
- Total Revenue
- 480.37
- Selling/ General/ Admin Expenses Total
- 98.7
- Depreciation/ Amortization
- 4.85
- Other Operating Expenses Total
- 22.78
- Total Operating Expense
- 141.53
- Operating Income
- 338.84
- Net Income Before Taxes
- 245.87
- Net Income
- 183.71
- Diluted Normalized EPS
- 6.63
- Period
- 2023-06-30
- Period
- 2023-06-30
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Five Star Business Finance Technical
Moving Average
SMA
- 5 Day827.25
- 10 Day817.51
- 20 Day801.21
- 50 Day761.14
- 100 Day769.23
- 300 Day747.31
Five Star Business Finance Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Global Health
- 1104.4
- 36.5
- 3.42
- 1513.75
- 707.6
- 29649.54
- Emcure Pharmaceuticals
- 1479.2
- 0.15
- 0.01
- 1577.5
- 1226.5
- 27971.43
- Five Star Business Finance
- 901.05
- 6.6
- 0.74
- 903.2
- 601
- 26351.14
- Nuvama Wealth Management
- 7327.4
- 425.8
- 6.17
- 7100
- 2301
- 25872.02
- Bikaji Foods International
- 908.65
- 26.6
- 3.02
- 1005
- 450.45
- 22718.09
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Global Health
- 60.15
- 9.88
- -
- -
- Emcure Pharmaceuticals
- 56
- 9.49
- 19.6
- 7.81
- Five Star Business Finance
- 30.02
- 5.04
- 16.12
- 37
- Nuvama Wealth Management
- 41.96
- 8.43
- -
- -
- Bikaji Foods International
- 83.4
- 18.13
- 16.71
- 7.5
Five Star Business Finance Shareholding
Shareholding Pattern
*Promoter pledging: 0%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-Oct-24
- Quarterly Results
- 17-Aug-24
- To consider issue of Warrants
- 31-Jul-24
- Quarterly Results
- 30-Apr-24
- Audited Results
- 01-Feb-24
- Quarterly Results
- 31-Oct-23
- Quarterly Results
- 29-Jul-23
- Quarterly Results
- 09-May-23
- Audited Results
- 25-Feb-23
- Others
- 28-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 16-Sept-23
- 16-Aug-23
- AGM